Related Experiment Video
Updated: Jun 20, 2026

05:44
Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
[Animal models in neurology: prospects and limitations]
E Mix1, H Meyer-Rienecker, U K Zettl
1Klinik und Poliklinik für Neurologie, Universität Rostock, Gehlsheimer Strasse 20, Rostock. eilhard.mix@med.uni-rostock.de
Fortschritte Der Neurologie-Psychiatrie
|August 18, 2009
Summary
Animal models are crucial for studying neurological diseases like multiple sclerosis (MS). Developing new models and biomarkers is essential for advancing research and clinical applications in neurology.
Area of Science:
- Neurology
- Immunology
- Pathology
Context:
- Animal models are vital for understanding the causes, progression, and treatment of neurological disorders.
- Experimental autoimmune encephalomyelitis (EAE) serves as a key model for multiple sclerosis (MS) research.
- Current models are insufficient for addressing all aspects of neurological disease research.
Purpose:
- To discuss the benefits and limitations of animal models in neurological disease research.
- To highlight the need for diverse animal models for studying various neurological conditions.
- To emphasize the requirement for novel biomarkers to enhance the clinical translation of experimental findings.
Summary:
- This review examines the utility and drawbacks of animal models, particularly EAE for MS.
- It stresses the necessity for a broader range of models to investigate the genetics, pathogenesis, diagnostics, and treatment of inflammatory, degenerative, ischemic, traumatic, and neoplastic neurological diseases.
- The abstract also points out the limited availability of alternative methods like cell cultures and computer simulations.
Impact:
- Improved understanding of neurological disease mechanisms.
- Development of more effective diagnostic tools and therapeutic strategies for neurological conditions.
- Enhanced translation of preclinical research findings into clinical practice through better experimental design and biomarker discovery.